Medicines (MDCO) Investors Overreacting, Says RBC
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
UPDATE: The Medicines Company (MDCO) Sinks
July 12, 2013 11:08 AM EDT(Updated - July 12, 2013 11:12 AM EDT)
The Medicines Company (Nasdaq: MDCO) stock declined on Friday. The fall follows news the U.S. District Court adapted Hospira's (NYSE: HSP) definitions in claim construction for Medicines' Angiomax patents, according to Bloomberg.... More
